Thomas John Charles
SEC insider (Form 3/4/5 filer). CIK 0002114900. EVP, General Counsel at Krystal Biotech, Inc. (KRYS). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 25, 2026. Located in PITTSBURGH, PA.
Companies Thomas John Charles has filed insider reports for
- Krystal Biotech, Inc. (KRYS): Officer, EVP, General Counsel
Thomas John Charles
CIK: 0002114900
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (66.7%)
Position reduction
Option Exercises (M)1 (33.3%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KRYS
Krystal Biotech, Inc.
Officer